RCSI has confirmed that CyberPsychology will no longer be a core research focus at RCSI.

This decision reflects a strategic review of our research focus to better align with our broader institutional objectives and to increase the impact of our research through greater investment in areas of core expertise.

“Investment in research is critical to the quality of our educational activities and our mission to enhance human health and earlier this year, we announced very ambitious plans to greatly support the College’s research strategy which aims to transfer research discoveries more quickly in to clinical practice for the benefit of patients. This represents an increased investment of €25 million, said Professor Cathal Kelly, RCSI Chief Executive.

As part of our strategy we are consolidating our research efforts into core research themes (Advanced Biomaterials, Stem Cells and Therapeutic Delivery; Cancer; Infection, Immunity & Inflammation; Population Health and Health Services; Respiratory Diseases; Neurological and Psychiatric Disorders; Cardiovascular Diseases; Health Professions Education (HPE). Biostatistics, Bioinformatics and Health Outcomes) and supporting these with a step-change investment in staff recruitment and infrastructure.

“Mary Aiken has passionately led this new emerging field and we wish her continued success in her important work for the future”, Prof Kelly continued.

We believe this research can thrive and reach its potential in an institution with a greater expertise in this highly specialised area. We will support an orderly wind down of this research area and support its transfer to ensure its continued momentum.